1/31
Looks like no tags are added yet.
define hypersensitivity
excessive or inappropriate immune response following repeated or prolonged antigen exposure, resulting in tissue damage
what are the 4 classifications of hypersensitivity reactions
type I
type II
type III
type IV
mechanism behind type I
antibody-antigen reaction involving IgE-mediated mast cell and basophil degranulation
mechanism behind type II
antibody-antigen reaction involving IgG or IgM binding to cell surface or extracellular matrix antigens
mechanism behind type III
antibody-antigen reaction involving deposition of antibody–antigen immune complexes in tissues
mechanism behind type IV
antibody-independant reaction involving direct immune cell attack, mediated by T cells
how quickly does type I hypersensitivity occur
Immediate hypersensitivity
It typically occurs within minutes of allergen exposure
which antibody is responsible for type I hypersensitivity
Immunoglobulin E (IgE)
what type of:
antigens
environmental allergens
commonly trigger type I hypersensitivity
antigens
protein antigens
environmental allergens:
pollen
house dust mite faecal partciles
fungal hyphae
fungal spores
animal skin flakes
which clinical conditions are associated with type I hypersensitivity
hay fever
chronic rhinitis
asthma
anaphylaxis
common food allergies and their percent allergenicity

sensitisatio and allergic response
what is sensitisation in type I hypersensitivity
initial exposure to an allergen that leads to IgE production and IgE binding to mast cells and basophils
what happens to allergen during initial exposure
it is processed by antigen-presenting cells, such as macrophages, and allergenic epitopes are presented to TH2 cells through MHC class II
which type of T helper cells is involved in type I allergic responses
type 2 helper T cells (TH2 cells)
which three cytokines are secreted by T cells to promote IgE production
IL-4
IL-5
IL-13
role of IL-4, IL-5 and IL-13 in Type I hypersensitivity
they promote rapid antibody isotype switching and IgE production by plasma cells
which cells produce IgE antibodies following B cell activation
plasma cells
where does secreted IgE bind after production
To specific high-affinity Fc receptors on tissue mast cells and circulating basophils
what is the purpose of IgE binding to mast cells during sensitisation
it primes the mast cells so they can respond rapidly when the same allergen is encountered again
what happens when an allergen is encountered for a second time
the allergen cross-links two cell-bound IgE molecules, triggering mast cell and basophil degranulation
what is mast cell degranulation
release of inflammatory mediators stored in the mast cell granules, together with production of additional mediators
why is the type I response described as biphasic
because there is an early phase and late phase
when does early phase of type I hypersensitivity occur and what does it involve
within approximately 20 minutes
It involves IgE–antigen interactions and the release of pre-existing immune mediators
when does the late phase occur, and which mediators are involved
approximately 2–4 hours after exposure
It involves newly synthesised prostaglandins, leukotrienes and platelet-activating factor

summary of sensitisation in type I reactions

what is the primary diagnostic method for immediate hypersensitivity
skin testing usually involving intraderemal infection of allergen
what is the characteristic skin response following a positive immediate hypersensitivity test
wheal and flare reaction
what causes wheal in wheal and flare reaction
histamine causes increased vascular permeability, allowing serum to move out of skin capillaries and produce local swelling
what causes flare
Vasodilation around the edge of the lesion, producing a larger erythematous area
how quickly does wheal and flare response develop and last for
it develops within 5–15 minutes and can last for 30 minutes or longer
what does a positive skin test indicate, and does it always predict clinical allergy
it indicates sensitisation to an allergen, but allergen exposure and clinical risk do not necessarily have a simple relationship